Search

Your search keyword '"Forget, Evelyn L"' showing total 274 results
Start Over Author "Forget, Evelyn L"
274 results on '"Forget, Evelyn L"'

27. Women and economics: New historical perspectives

Author

Chassonnery-Zaïgouche, Cléo, Forget, Evelyn L., and Singleton, John D.

Subjects
Wirtschaftswissenschaft, Geschlecht, ddc:330, Ökonomen
Abstract

This essay is the introduction to the History of Political Economy Annual Supplement on 'Women and Economics: New Historical Perspectives.' We first reflect on the historiography of economics and the relative absence of women and gender in the mainstream of the field. Three approaches to the history of women and economics are delineated: making visible women economists, outlining the impact of including women in a broader narrative about economics, and analyzing gender metaphors in economic thought. We then preview and describe the nine contributions included in the volume. In the last of section, we consider 'what's next' for this research agenda, arguing that there are two important challenges to historians of economics. The first challenge concerns the consequences of delegating women and gender to a separate history. The second challenge concerns the 'silences' of unwritten, un-developed, and un-preserved work in the history of economics and how the community engaged with the past of economics should reflect on these.

Published
2022

28. Joanna Rostek, Women’s Economic Thought in the Romantic Age: Towards a Transdisciplinary Herstory of Economic Thought

Author

Forget, Evelyn L.

Abstract

Joanna Rostek has published an ambitious book designed to create the foundations for a female-centric history of economic thought focused on the “Romantic Age”, which she identifies with the years 1780-1830 (7). Part I outlines a transdisciplinary methodology for her historical project, while part II applies the method to the writing of seven English women she identifies as economists. Rostek examines Sarah Chapone, Mary Wollstonecraft, Mary Hays and Mary Robinson who wrote about the economic...

Published
2021

29. Is herpes zoster vaccination likely to be cost-effective in Canada?

Author

Peden, Alexander D., Strobel, Stephenson B., and Forget, Evelyn L.

Subjects
Shingles (Disease) -- Prevention, Medical care, Cost of -- Measurement, Cost benefit analysis -- Methods, Viral vaccines -- Economic aspects, Cost benefit analysis, Government, Health, Health care industry
Abstract

OBJECTIVES: To synthesize the current literature detailing the cost-effectiveness of the herpes zoster (HZ) vaccine, and to provide Canadian policymakers with cost-effectiveness measurements in a Canadian context. METHODS: This article builds on an existing systematic review of the HZ vaccine that offers a quality assessment of 11 recent articles. We first replicated this study, and then two assessors reviewed the articles and extracted information on vaccine effectiveness, cost of HZ, other modelling assumptions and QALY estimates. Then we transformed the results into a format useful for Canadian policy decisions. Results expressed in different currencies from different years were converted into 2012 Canadian dollars using Bank of Canada exchange rates and a Consumer Price Index deflator. Modelling assumptions that varied between studies were synthesized. We tabled the results for comparability. SYNTHESIS: The Szucs systematic review presented a thorough methodological assessment of the relevant literature. However, the various studies presented results in a variety of currencies, and based their analyses on disparate methodological assumptions. Most of the current literature uses Markov chain models to estimate HZ prevalence. Cost assumptions, discount rate assumptions, assumptions about vaccine efficacy and waning and epidemiological assumptions drove variation in the outcomes. This article transforms the results into a table easily understood by policy-makers. CONCLUSION: The majority of the current literature shows that HZ vaccination is cost-effective at the price of $100,000 per QALY. Few studies showed that vaccination cost-effectiveness was higher than this threshold, and only under conservative assumptions. Cost-effectiveness was sensitive to vaccine price and discount rate. KEY WORDS: Review; cost-benefit analysis; public policy OBJECTIFS: Faire une synthese de la litterature actuelle sur le rapport cout-efficacite du vaccin contre le virus de l'herpes zoster (zona) et fournir aux responsables des politiques du Canada des indicateurs cout-efficacite dans un contexte canadien. METHODE: Cet article fait fond sur une revue systematique existante qui evalue la qualite de 11 articles recents portant sur le vaccin contre le zona. Nous avons d'abord reproduit l'etude, apres quoi deux evaluateurs ont examine les articles et en ont extrait l'information sur l'efficacite du vaccin, le cout du zona, les autres postulats de modelisation et les estimations des annees de vie ponderees par la qualite (AVPQ). Ensuite, nous avons transpose les resultats sous une forme utile aux decisions strategiques canadiennes. Les resultats, exprimes en differentes devises pour differentes annees, ont ete convertis en dollars canadiens de 2012 a l'aide des taux de change de la Banque du Canada et d'un deflateur : l'indice des prix a la consommation. Les postulats de modelisation variables d'une etude a l'autre ont ete synthetises. Nous avons mis les resultats en tableaux pour pouvoir les comparer. SYNTHESE: La revue systematique de Szucs presentait une evaluation methodologique exhaustive de la litterature pertinente. Cependant, les resultats des diverses etudes etaient presentes dans toutes sortes de devises, et les analyses etaient fondees sur des postulats methodologiques disparates. La plupart des articles recents font appel aux modeles en chaines de Markov pour estimer la prevalence du zona. Les postulats relatifs aux couts, aux taux d'actualisation, a l'efficacite potentielle du vaccin, a la baisse de l'immunite conferee par le vaccin, ainsi que les postulats epidemiologiques, ont fait varier les resultats. Notre article transpose ces resultats dans un tableau facile a comprendre pour les responsables des politiques. CONCLUSION: Selon la majorite des articles recents, la vaccination contre le zona est rentable au prix de 100 000 $ par AVPQ. Peu d'etudes indiquent un rapport cout-efficacite de la vaccination superieur a ce seuil, et seulement sur la base de postulats prudents. Le rapport cout-efficacite etait sensible au prix et au taux d'actualisation du vaccin. MOTS CLES: revue de la litterature; analyse cout-benefice; politique publique, The varicella zoster virus (VZV) is responsible for both the common and usually mild childhood chickenpox infection (varicella zoster) and the herpes zoster (HZ) or shingles infection most common among [...]

Published
2014

36. Gender in classical economics

Author

Dimand, Robert W., Forget, Evelyn L., and Nyland, Chris

Subjects
Social status -- Demographic aspects, Economic development -- Forecasts and trends, Women in public life -- Evaluation, Market trend/market analysis, Economics
Abstract

A retrospective study into the insights on the economic and social status of women by different classical economists is presented. It was seen that even though these writing strongly upheld women's legal and economic rights, neglecting their economic role in society the economic status of women did advance with some key steps facilitated by arguments of Adam smith and others.

Published
2004

37. Passion and Craft: Economists at Work. (Book Reviews)

Author

Forget, Evelyn L.

Subjects
Economics, Sociology and social work
Abstract

Passion and Craft: Economists at Work. Edited by Michael Szenberg, Ann Arbor: University of Michigan Press, 1998, xvii, 314 pp. $22.95 (paper), ISBN 0-472-06685-4. Lori Arviso Alvord, the first Navajo [...]

Published
2003

50. Examining prescription opioid use, misuse and use disorders for association with socio-demographic predictors, BMI, suicidal behavior and health services use in the US adult population

Author

Forget, Evelyn L. (Community Health Sciences) Shooshtari, Shahin (Community Health Sciences) Driezen, Pete (University of Waterloo), Ahmed, Rashid (Community Health Sciences), Chowdhury, Nasrin Ahosan, Forget, Evelyn L. (Community Health Sciences) Shooshtari, Shahin (Community Health Sciences) Driezen, Pete (University of Waterloo), Ahmed, Rashid (Community Health Sciences), and Chowdhury, Nasrin Ahosan

Abstract

Problem: The prescription opioid epidemic in the United States is associated with negative health and social outcomes. Examining the association of socio-demographic predictors, BMI, suicidal behavior and health services use in prescription opioid use without misuse (POU), prescription opioid misuse without use disorders (POMU) and prescription opioid use disorder (POUD) samples is important to make necessary intervention in each sample to prevent the expansion of epidemic. Method: A cross-sectional secondary data analysis using the 2016-2017 National Survey on Drug Use and Health (NSDUH) data was conducted. The sample size for the past year POU was 24,400; POMU was 3,771; POUD was 721 and the reference sample who did not have any use of prescription opioid in the past year was 55,304. Result: The prevalence of the past year POU is 32.4 %, POMU is 5.2 % and POUD is 1.0 %. Age ≥ 50 and age 30-49 years have a higher risk of POU [OR 1.37; OR 1.44] and age ≥ 50 has a lower risk of POMU [0.54] than age 18-29 years. Males have a lower risk of POU [0.92] and a higher risk of POMU [1.31] and POUD [1.66] than females. Non-Hispanic Whites have a higher risk of POU [1.33], POMU [1.42] and POUD [3.68] than Hispanics. Single people have a higher risk of POMU [OR 1.27] than married individuals. ‘Medicaid only’ insurance coverage has a higher risk of POU, POMU, POUD than almost all other insurance types. Obesity [OR 1.45] and overweight [OR 1.18] have a higher risk of POU than normal BMI. Suicidal behaviour has a higher risk of POU [1.25] < POMU [2.58] < POUD [3.37]. More than 1 emergency department visit has a higher risk of POMU [2.10] < POU [2.22] < POUD [3.74]; more than 1 overnight hospital stay has a higher risk of POMU [1.40] < POUD [1.70] < POU [2.03] ; more than 1 outpatient department visit has a higher risk of POMU [1.29] < POUD [1.43] < POU [2.38] and mental health services use has a higher association with POU [1.49] < POMU [1.90] < POUD [4.34] when compared with no u

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results